|
Piperazine dihydrochloride |
CAS 142-64-3 | ||
C4H10N2 2HCl |
RTECS TL4025000 | ||
Synonyms & Trade Names Piperazine hydrochloride [Note: The monochloride, C4H10N2 HCl, is also commercially available.] |
DOT ID & Guide |
Exposure
|
NIOSH REL: TWA 5 mg/m3 | ||
OSHA PEL†: none | |||
IDLH N.D. See: IDLH INDEX | Conversion |
Physical Description White to cream-colored needles or powder. |
|||
MW: 159.1 |
BP: ? |
MLT: 635°F |
Sol: 41% |
VP: ? |
IP: ? |
|
Sp.Gr: ? |
Fl.P: ? |
UEL: ? |
LEL: ? |
|
Combustible Solid, but does not ignite easily. | |||
Incompatibilities & Reactivities Water [Note: Slightly hygroscopic (i.e., absorbs moisture from the air).] |
Measurement Methods None available See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations Not available. |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin, respiratory system; skin burns, sensitization; asthma; gastrointestinal upset, headache, nausea, vomiting, incoordination, muscle weakness | |
Target Organs
Eyes, skin, respiratory system, central nervous system |
See also: INTRODUCTION |